SCHEMBL7746658

SCHEMBL7746658

CCCCC(=O)Nc1oc(-c2ccccc2O)nc1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.55
FLT1 P17948 1/20 0.55
FLT4 P35916 1/20 0.55
HPGD P15428 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
USP2 O75604 1/20 0.48
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
ADORA1 P30542 4/20 0.48
SOAT1 P35610 2/20 0.46
ADORA3 P0DMS8 1/20 0.46
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 4/20 0.43
HSD17B10 Q99714 3/20 0.43
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
CETP P11597 1/20 0.41
PLTP P55058 1/20 0.41
ADORA2A P29274 2/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739022 0.90 KDR (0.54) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7739024 0.86 KDR (0.50) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744659 0.86 KDR (0.50) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7746627 0.84 KDR (0.48) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744162 0.83 KDR (0.45) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744083 0.83 KDR (0.47) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744192 0.82 KDR (0.51) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744651 0.82 HPGD (0.51) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7739009 0.82 KDR (0.77) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744081 0.82 FLT1 (0.46) KDRFLT1FLT4HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed